These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proceedings of the International Symposium on Radiohalogens. Banff, Alberta, Canada, 10-11 September 1985. Int J Rad Appl Instrum A; 1986; 37(8):803-921. PubMed ID: 3021682 [No Abstract] [Full Text] [Related]
4. Veterinary nuclear medicine. Krzemiński M; Lass P; Teodorczyk J; Krajka J Nucl Med Rev Cent East Eur; 2004; 7(2):177-82. PubMed ID: 15968607 [No Abstract] [Full Text] [Related]
5. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810 [TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals labelled with halogen isotopes. Int J Rad Appl Instrum A; 1986; 37(8):645-921. PubMed ID: 3021665 [No Abstract] [Full Text] [Related]
8. Recent progress using the Staudinger ligation for radiolabeling applications. Mamat C; Gott M; Steinbach J J Labelled Comp Radiopharm; 2018 Mar; 61(3):165-178. PubMed ID: 28895180 [TBL] [Abstract][Full Text] [Related]
9. Options to meet the future global demand of radionuclides for radionuclide therapy. Das T; Pillai MR Nucl Med Biol; 2013 Jan; 40(1):23-32. PubMed ID: 23116551 [TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods. Eberle AN; Mild G J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167 [TBL] [Abstract][Full Text] [Related]
12. Development and applications of radioactive nanoparticles for imaging of biological systems. Lewis MR; Kannan R Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):628-40. PubMed ID: 25196269 [TBL] [Abstract][Full Text] [Related]
13. Approaches to improve cellular retention of radiohalogen labels delivered by internalising tumour-targeting proteins and peptides. Tolmachev V; Orlova A; Lundqvist H Curr Med Chem; 2003 Nov; 10(22):2447-60. PubMed ID: 14529484 [TBL] [Abstract][Full Text] [Related]
14. Paving the way to personalized medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory. Srivastava SC Semin Nucl Med; 2012 May; 42(3):151-63. PubMed ID: 22475424 [TBL] [Abstract][Full Text] [Related]
15. [Medical use of isotopes]. Nosslin B Lakartidningen; 1976 Mar; 73(13):1197. PubMed ID: 1263635 [No Abstract] [Full Text] [Related]
16. Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Wilbur DS Bioconjug Chem; 1992; 3(6):433-70. PubMed ID: 1463775 [TBL] [Abstract][Full Text] [Related]
17. [Application of radiometallic compounds for medical diagnosis and therapy]. Saji H Yakugaku Zasshi; 2008 Mar; 128(3):323-32. PubMed ID: 18311050 [TBL] [Abstract][Full Text] [Related]
18. Decay data and production yields of some non-standard positron emitters used in PET. Qaim SM Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879 [TBL] [Abstract][Full Text] [Related]
20. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept. Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]